Oncopeptides AB

ONPPF:OTCPK
RT Quote | Exchange | USD
Last | 12/16/20 EST
20.38UNCH (UNCH)
52 week range
19.39 - 20.38

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close20.38
  • 52 Week High20.38
  • 52 Week High Date12/16/20
  • 52 Week Low19.39
  • 52 Week Low Date12/10/20
  • Market Cap1,304.77M
  • Shares Out67.77M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Oncopeptides AB News

There is no recent news for this security.

Latest ONPPF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Oncopeptides AB is a Sweden-based clinical development pharmaceutical company, which is primarily engaged in the healthcare industry. The Company focuses on research and development of cancer treatment solutions. The Company's product Ygalo is a peptidase potentiated alkylator, a type of cytotoxic drug that is targeted for use in the treatment of multiple myeloma. Ygalo is an alkylating agent that leverages the overrepresentation of peptidase enzymes in cancer cells to rise...
Per Wold-Olsen
Chairman
Jakob Lindberg M.D.
Chief Executive Officer
Eva Nordstrom
Chief Operating Officer
Anders Martin-Lof
Chief Financial Officer
Klaas Bakker M.D.
Executive Vice President
Karolina Vilval
General Counsel
Address
Luntmakargatan 46, van 7
Stockholm
111 37
Sweden